Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13) Peptide
Quick Overview for Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13) Peptide (ABIN937498)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- DPRFFSNPRD FNPQHFLDKK GQFKKSDAFV PFSIGKRYCF GEGLARMELF
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CYP2 A13 antibody,
Alternative Names: CYP2A13 control peptide, CYP2A13 antibody Blocking Peptide, Anti-CYP2A13 Blocking Peptide, Cytochrome P450 Family 2 Subfamily A Polypeptide 13 Blocking Peptide, CPAD Blocking Peptide, CYP2A Blocking Peptide, CYP2A13, CYPA13-2, CYPA13 2, CYPA13-2 Blocking Peptide, CYPA13 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- CYP2A13 (Cytochrome P450, Family 2, Subfamily A, Polypeptide 13 (CYP2A13))
-
Background
- CYP2A13 is a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. Although its endogenous substrate has not been determined, it is known to metabolize 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a major nitrosamine specific to tobacco.
-
Molecular Weight
- 54 kDa
Target
-